Form 4: Cannae Holdings Director Receives Stock Grant
Insider Transaction Report
Cannae Holdings, Inc. Director James B. Stallings JR was granted 7,818 shares of common stock, vesting over three years.
Summary
- James B. Stallings JR, a Director of Cannae Holdings, Inc. (CNNE), was granted 7,818 shares of common stock.
- The transaction occurred on November 12, 2025, with a reported price of $0 per share, indicating a grant.
- These restricted shares will vest in three equal annual installments, with the first vesting date on November 12, 2026.
- Following this transaction, Mr. Stallings beneficially owns a total of 34,279 shares of Cannae Holdings, Inc. common stock directly.
Sentiment
Score: 6
Explanation: The grant of restricted stock to a director is a positive event as it aligns the director's interests with shareholders, promoting long-term commitment, though it is a routine compensation matter.
Positives
- The grant of 7,818 shares of common stock to Director James B. Stallings JR aligns his interests with those of shareholders.
- Restricted stock grants are a common form of executive and director compensation, encouraging long-term commitment.
Negatives
- The shares are restricted and do not provide immediate liquidity, as they vest over a three-year period.
- The reported transaction price of $0 indicates a grant, not a purchase, meaning no direct cash investment by the director for these specific shares.
Risks
- The restricted stock is subject to a vesting schedule, meaning the director could forfeit unvested shares if certain conditions (e.g., continued service) are not met.
- The value of the granted shares is subject to the future market performance of Cannae Holdings, Inc.'s common stock.
Future Outlook
The vesting schedule for the restricted stock grant indicates a future commitment from the director, with shares vesting annually starting November 12, 2026, over a three-year period.
Industry Context
Granting restricted stock to directors is a standard practice in corporate governance across various industries, including financial services and holding companies, to incentivize long-term performance and align leadership interests with shareholder value.
Comparison to Industry Standards
- The practice of granting restricted stock to directors, such as James B. Stallings JR at Cannae Holdings, Inc., is consistent with compensation strategies observed in comparable companies within the financial services and diversified holding sectors.
- For instance, companies like Fidelity National Financial (FNF) or Black Knight (BKI, prior to acquisition) often utilize similar equity-based compensation plans for their non-employee directors to foster long-term alignment and retention.
- The vesting schedule over three years is also a common structure for such grants in the industry.
Stakeholder Impact
- Shareholders: The grant aligns the director's financial interests with long-term shareholder value creation, as the value of the shares is tied to the company's stock performance.
- Management/Employees: Reinforces a culture of equity-based compensation and long-term commitment among leadership.
Next Steps
- The restricted shares will vest in three equal annual installments, beginning on November 12, 2026.
Key Dates
| Date | Description |
|---|---|
| 11/12/2025 | Date of transaction: Grant of restricted common stock to James B. Stallings JR. |
| 11/13/2025 | Date the Form 4 was signed by Carol Nairn, as attorney-in-fact. |
| 11/12/2026 | First vesting date for the restricted stock grant, with shares vesting in three equal annual installments. |
Keywords
Cannae Holdings, CNNE, Form 4, Insider Transaction, Restricted Stock Grant, Director Compensation, Equity Compensation, James B. Stallings JR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.